News | Page 65 | Weill Department of Medicine

Dr. Moore Honored with NYAM Award

Dr. Anne MooreAnne Moore, M.D., Professor of Clinical Medicine and Medical Director of the Weill Cornell Breast Center, will be honored by The New York Academy of Medicine with the 2011 Academy Plaque for Exceptional Service to the Academy. Dr. Moore, a member of Weill Cornell's Division of Hematology and Medical Oncology for 35 years, specializes in the research and treatment of breast cancer. The Academy Plaque, one of the academy's most prestigious awards, will be presented to Dr. Moore at a... Read More

Global Health Center Receives $560K Grant from Mulago Foundation

Daniel W. Fitzgerald, M.D., Warren D. Johnson, Jr., M.D., and Robert N. Peck, M.D., and the Global Health Center secured a Mulago Foundation grant for $560,000 over three years to support health innovations at Weill Bugando Medical School in Tanzania.

Dr. Logio Appointed Siegel Distinguished Professor

Dr. Lia LogioHaving joined Weill Cornell Medical College in June as Vice Chair for Education in the Department of Medicine and Director of the Internal Medicine Residency Program, Lia S. Logio, M.D. has been appointed as the Herbert J. and Ann L. Siegel Distinguished Professor of Medicine effective January 1, 2011.The endowed professorship recognizes Dr. Logio's outstanding leadership in medical education and administration, as well as her innovations in education, patient safety and faculty... Read More

Dr. Melnick Reveals Genetic Pathway in AML

Dr. Ari MelnickAcute myelogenous leukemia (AML), with more than 12,000 new diagnoses each year, is a particularly stealthy cancer. But a team of researchers led by Ari M. Melnick, M.D., Associate Professor of Medicine at Weill Cornell Medical College, have caught it in the act. In research published this week in the online issue of Cancer Cell, Dr. Melnick and his colleagues elucidate how a mutation in the genes that produce the metabolic enzymes IDH1 and IDH2 leads directly to the... Read More

Dr. Rhee Receives Two Grants from Gates Foundation

A graduate of Cornell University, Dr. Kyu Rhee is one of only nine grantees to receive further funding from the Bill & Melinda Gates Foundation, through the Grand Challenges Exploration Program. Dr. Carl Nathan was another of these nine grantees to receive follow-on funding. In addition, each received a second grant through the TB Drug Accelerator Program (two of only seven), an independent program that is part of the larger Gates "Grand Challenges" initiative.Dr. Kyu RheeKnown for his... Read More

New Combination Therapy Proves Highly Effective against non-Hodgkin's Lymphoma Cells

Dr. Ari MelnickResearch from the laboratory of Ari M. Melnick, M.D., Division of Hematology and Medical Oncology, has resulted in a promising new combinatorial therapy for diffuse large B cell lymphoma, an aggressive and rapidly progressive cancer that affects approximately 21,000 new people each year. This research, published in The Journal of Clinical Investigation, may hold significant implications for patient survival rates.Diffuse large B cell lymphoma (DLBCL), a non-Hodgkin's lymphoma,... Read More

Dr. Hall-Ross Named Physician of the Year by Department of Nursing

Dr. Sandra Hall-RossSandra M. Hall-Ross, M.D., Assistant Professor of Clinical Medicine and Assistant Attending Physician, has been named Physician of the Year by NewYork-Presbyterian Hospital's Department of Nursing. Established in 2005, the award recognizes physicians who exemplify a spirit of collegiality and collaboration with the nursing staff.Each fall, the hospital nursing staff submit applications nominating doctors with whom they work for Physician of the Year. Letters of support are... Read More

ADVANCE Trial Advances to Superior Viral Response Rates Using Telaprevir

Dr. JacobsonIra M. Jacobson, M.D., Chief of Gastroenterology and Hepatology and the lead investigator of the ADVANCE trial, reported breakthrough findings at the 61st Annual Meeting of the American Association for the Study of Liver Disease in Boston on November 2, 2010. Adding a protease inhibitor – telaprevir – to the standard first-time treatment given to patients with hepatitis C resulted in a superior success rate. In fact, 75 percent of patients who received 12 weeks of therapy with... Read More

Department Physicians Elected to Institute of Medicine

David J. Skorton, M.D., President of Cornell University and a member of the Department of Medicine at Weill Cornell Medical College, and Joseph J. Fins, M.D., Chief of Weill Cornell's Division of Medical Ethics and an Attending Physician at NewYork-Presbyterian Hospital, have been elected to the National Academy of Sciences' Institute of Medicine. Announced yesterday at the IOM's 40th annual meeting in Washington, DC, the election is one of the highest honors in the field of health and medicine... Read More

Dr. Guzman Receives $1.5 Million NIH Director's New Innovator Award

Dr. Monica GuzmanMonica L. Guzman, Ph.D., Assistant Professor of Pharmacology in Medicine, Weill Cornell Medical College, is among this year's recipients of the National Institutes of Health Director's New Innovator Awards. Established in 2008 to stimulate highly innovative research and support promising new investigators, the five-year award is for $1.5 million.Dr. Guzman's work focuses on acute myeloid leukemia (AML), a blood cancer that starts in the bone marrow. Left untreated, AML is... Read More